Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study.

Long-term outcomes remain poor, and hence better treatment strategies are urgently needed in stage III NSCLC. Equally, more robust, prospective studies would help delineate the optimal treatment modality in these patients.